Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2024 Filed May 1, 2024 23:02 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 3,250 | $2.48 | $8,060.00 |
DisclosureSEC source: 0001415889-24-011914 · form4-05012024_110511.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 18:50 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-011707 · form4-04292024_100422.xml · derivative · entry 6 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,841 Underlying: Common Stock · 12,000 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 18:50 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 12,000 | $16.89 | $202,700.40 |
DisclosureSEC source: 0001415889-24-011707 · form4-04292024_100422.xml · nonDerivative · entry 2 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.5946 to $17.336. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 18:50 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 12,000 | $1.12 | $13,440.00 |
DisclosureSEC source: 0001415889-24-011707 · form4-04292024_100422.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| April 15, 2024 Filed Apr 15, 2024 23:03 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 80 | $20.68 | $1,654.18 |
DisclosureSEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 3 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,155 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $20.64 to $20.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 15, 2024 Filed Apr 15, 2024 23:03 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 1,190 | $19.94 | $23,728.96 |
DisclosureSEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 2 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,235 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.61 to $20.5558. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,580 | $0.00 Strike: $19.68 | $0.00 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · derivative · entry 10 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,742 Underlying: Common Stock · 4,580 shares Expires 2029-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F6 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 48,820 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · derivative · entry 9 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,820 shares Expires 2028-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F6 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 3,068 | $25.21 | $77,342.44 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 7 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,341 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $25.02 to $25.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 20,032 | $25.00 | $500,701.84 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 6 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,409 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.015 to $25.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 30,300 | $23.14 | $701,023.83 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 5 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,441 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 4,580 | $19.68 | $90,134.40 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 4 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 48,820 | $12.60 | $615,132.00 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 3 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 19:06 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-010830 · form4-04152024_110409.xml · derivative · entry 4 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,550 Underlying: Common Stock · 30,000 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F4 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 19:06 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 30,000 | $25.04 | $751,332.00 |
DisclosureSEC source: 0001415889-24-010830 · form4-04152024_110409.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 19:06 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionCommon Stock | 30,000 | $1.12 | $33,600.00 |
DisclosureSEC source: 0001415889-24-010830 · form4-04152024_110409.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 19:05 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 47,709 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-010828 · form4-04152024_110408.xml · derivative · entry 6 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,841 Underlying: Common Stock · 47,709 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 19:05 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 47,709 | $25.04 | $1,194,700.15 |
DisclosureSEC source: 0001415889-24-010828 · form4-04152024_110408.xml · nonDerivative · entry 2 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 19:05 UTC |
Kintz SamuelDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 47,709 | $1.12 | $53,434.08 |
DisclosureSEC source: 0001415889-24-010828 · form4-04152024_110408.xml · nonDerivative · entry 1 Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:06 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,903 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001415889-24-010831 · form4-04152024_110448.xml · derivative · entry 4 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,717 Underlying: Common Stock · 14,903 shares Expires 2031-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F4 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 14, 2021. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:06 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 17,500 | $25.03 | $438,098.50 |
DisclosureSEC source: 0001415889-24-010831 · form4-04152024_110448.xml · nonDerivative · entry 2 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:06 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 14,903 | $2.48 | $36,959.44 |
DisclosureSEC source: 0001415889-24-010831 · form4-04152024_110448.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:04 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001415889-24-010827 · form4-04152024_110419.xml · derivative · entry 4 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 225,370 Underlying: Common Stock · 14,000 shares Expires 2031-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:04 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 10,223 | $25.04 | $255,969.61 |
DisclosureSEC source: 0001415889-24-010827 · form4-04152024_110419.xml · nonDerivative · entry 3 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.69 to $25.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:04 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,777 | $23.88 | $90,179.27 |
DisclosureSEC source: 0001415889-24-010827 · form4-04152024_110419.xml · nonDerivative · entry 2 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,223 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.65 to $24.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:04 UTC |
Hohl BenjaminCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 14,000 | $2.48 | $34,720.00 |
DisclosureSEC source: 0001415889-24-010827 · form4-04152024_110419.xml · nonDerivative · entry 1 Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:03 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 649 | $25.00 | $16,225.00 |
DisclosureSEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 4 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 28,567 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F5 · ownership.nature: The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:03 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 5,045 | $25.03 | $126,279.38 |
DisclosureSEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138.425 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:02 UTC |
Collins Helen LouiseCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001415889-24-010823 · form4-04152024_110437.xml · derivative · entry 3 Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,084 Underlying: Common Stock · 20,000 shares Expires 2031-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F3 · derivative.exercise_date: The option, originally for 287,084 shares, vested as to one-fourth of the shares on June 17, 2022, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:02 UTC |
Collins Helen LouiseCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 20,000 | $25.07 | $501,478.00 |
DisclosureSEC source: 0001415889-24-010823 · form4-04152024_110437.xml · nonDerivative · entry 2 Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 23:02 UTC |
Collins Helen LouiseCHIEF MEDICAL OFFICER
|
Exercise / conversionCommon Stock | 20,000 | $2.48 | $49,600.00 |
DisclosureSEC source: 0001415889-24-010823 · form4-04152024_110437.xml · nonDerivative · entry 1 Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,600 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · derivative · entry 8 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,820 Underlying: Common Stock · 13,600 shares Expires 2028-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F6 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 13,600 | $21.01 | $285,744.16 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 2 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,341 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.00 to $21.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 22:23 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 13,600 | $12.60 | $171,360.00 |
DisclosureSEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:39 UTC |
Kunkel Lori AnneDirector
|
GrantStock Option (right to buy) · Derivative | 37,882 | $0.00 Strike: $18.30 | $0.00 |
DisclosureSEC source: 0001415889-24-010678 · form4-04112024_120413.xml · derivative · entry 1 Kunkel Lori Anne · CIK 0001536368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,882 Underlying: Common Stock · 37,882 shares Expires 2034-04-08 F1 · derivative.exercise_date: 1/36th of the shares subject to the option will vest on May 8, 2024 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:35 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 544 | $19.40 | $10,552.46 |
DisclosureSEC source: 0001415889-24-010676 · form4-04112024_120405.xml · nonDerivative · entry 2 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,597 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.245 to $19.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:35 UTC |
Patel AnishCHIEF OPERATING OFFICER
|
SaleCommon Stock | 4,331 | $18.50 | $80,134.33 |
DisclosureSEC source: 0001415889-24-010676 · form4-04112024_120405.xml · nonDerivative · entry 1 Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,141 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.19 to $19.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:40 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,485 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0001415889-24-010520 · form4-04092024_120438.xml · derivative · entry 3 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,420 Underlying: Common Stock · 3,485 shares Expires 2028-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:40 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 3,485 | $19.15 | $66,729.39 |
DisclosureSEC source: 0001415889-24-010520 · form4-04092024_120438.xml · nonDerivative · entry 2 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,341 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.05 to $19.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:40 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 3,485 | $12.60 | $43,911.00 |
DisclosureSEC source: 0001415889-24-010520 · form4-04092024_120438.xml · nonDerivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:30 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001415889-24-010228 · form4-04042024_010402.xml · derivative · entry 6 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,550 Underlying: Common Stock · 12,000 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:30 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 71 | $19.36 | $1,374.40 |
DisclosureSEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 4 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $19.355 to $19.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:30 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 9,577 | $18.80 | $180,083.99 |
DisclosureSEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 3 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $18.35 to $19.325. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:30 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 2,352 | $17.72 | $41,687.32 |
DisclosureSEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 2 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,648 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.335 to $18.255. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:30 UTC |
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
|
Exercise / conversionCommon Stock | 12,000 | $1.12 | $13,440.00 |
DisclosureSEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 1 Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:32 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,143 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0001415889-24-010232 · form4-04042024_010458.xml · derivative · entry 5 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,428 Underlying: Common Stock · 3,143 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F5 · derivative.exercise_date: The option, originally for 32,849 shares, which share amount reflects the Stock Split, vested as to one-fourth of the shares on January 28, 2023, and the remainder of the shares vest in 12 equal quarterly installments thereafter. F4 · balance_after: The number of shares beneficially owned reflect the 1-for-4 reverse stock split of the Issuer's Common Stock effected February 23, 2023 (the "Stock Split"). Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:32 UTC |
Ballal Rahul D.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 94 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0001415889-24-010232 · form4-04042024_010458.xml · derivative · entry 4 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,905 Underlying: Common Stock · 94 shares Expires 2028-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof. F4 · balance_after: The number of shares beneficially owned reflect the 1-for-4 reverse stock split of the Issuer's Common Stock effected February 23, 2023 (the "Stock Split"). Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:32 UTC |
Ballal Rahul D.Director
|
SaleCommon Stock | 3,237 | $19.08 | $61,758.40 |
DisclosureSEC source: 0001415889-24-010232 · form4-04042024_010458.xml · nonDerivative · entry 3 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,341 F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:32 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 3,143 | $5.52 | $17,349.36 |
DisclosureSEC source: 0001415889-24-010232 · form4-04042024_010458.xml · nonDerivative · entry 2 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:32 UTC |
Ballal Rahul D.Director
|
Exercise / conversionCommon Stock | 94 | $12.60 | $1,184.40 |
DisclosureSEC source: 0001415889-24-010232 · form4-04042024_010458.xml · nonDerivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.